Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 13 Show results per page	View Search Criteria \| Help With Results

Last Modified: 12/1/1999


1.		Phase III Randomized, Double-Blind Study of Warfarin vs Placebo for Chemoprevention of Thrombosis in Central Venous Access Catheters in Cancer Patients (Summary Last Modified 12/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				over 18				NCI				CCCWFU-97194 NCI-P95-0064

Last Modified: 8/10/2007


2.		Phase III MACC (MTX/ADR/CCNU/CTX) vs MACC/Warfarin vs MACC Alternating with MEPH (MITO/VP-16/CACP/HMM) for Extensive Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				21 to 69				NCI				CLB-8084 CALGB-8084


3.		Phase III Randomized Study of Adjuvant Anticoagulation Therapy with Warfarin for Stage II/III Adenocarcinoma of the Colon

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								SEG-GI-82351


4.		Phase III Adjuvant Chemotherapy with Urokinase or Urokinase/Warfarin for Resectable Dukes B/C Adenocarcinoma of the Colon and Rectum

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 70								EORTC-19793 UKM-HH-1

Last Modified: 12/1/1991


5.		Phase III Randomized Comparison of Warfarin vs No Warfarin in Combination with Intensive Chemotherapy Using ACE (ADR/CTX/VP-16) and PCE (CDDP/CTX/VP-16) plus Primary Thoracic and Prophylactic Whole-Brain Radiotherapy in Limited Small Cell Lung Cancer (Summary Last Modified 12/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				CLB-8534 CALGB-8534


6.		Phase I/II Pilot Study of Intensive Combination Chemotherapy with Sequential ACE (ADR/CTX/VP-16) and PCE (CACP/CTX/VP-16) plus Chest Irradiation and Warfarin in Patients with Limited Small Cell Carcinoma of the Lung

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				over 21				NCI				CLB-8532 CALGB-8532


7.		Adjuvant Chemotherapy with DTIC or BCNU/ACT-D/VCR with or without Anticoagulation for Resectable Stage II-III Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D78-026-202 RPMI-PPC-580

Last Modified: 7/1/2002 First Published: 4/1/2001


8.		Phase II Study of Docetaxel, Estramustine, and Warfarin Followed by Doxorubicin and Ketoconazole in Patients With High-Risk, Androgen-Independent Prostate Cancer (Summary Last Modified 07/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Closed				18 and over				NCI				MSKCC-00113 NCI-G01-1927, NCT00014352

Last Modified: 9/1/1987


9.		Phase II Pilot Study of Combined Warfarin/RA-233 in Patients with Advanced Cancer (Summary Last Modified 09/87)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								DMS-8308 NCI-V87-0190

Last Modified: 1/20/2006 First Published: 8/24/2004


10.		Phase I Study of Low-Dose Warfarin and Vatalanib in Patients With Advanced Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI, Pharmaceutical / Industry				UCLA-0403067-01 NOVARTIS-CPTK7870113, NCT00091299

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute